COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Given the impracticality of continuously testing people diagnosed with COVID-19 to determine whether they remain infectious, the Centers for Disease Control and Prevention (CDC) issued guidance this week on a symptom-based strategy for discontinuing isolation of persons with COVID-19.
The Centers for Medicare & Medicaid Services (CMS) this week announced regulations requiring nursing homes to fully cooperate with Centers for Disease Control and Prevention (CDC) surveillance of the spread of COVID-19 by reporting cases of COVID-19 directly to the CDC.
The Centers for Disease Control and Prevention (CDC) is now reporting national data on confirmed COVID-19 cases by both race and ethnicity.
The Centers for Medicare and Medicaid Services (CMS) April 9 temporarily suspended a number of rules so that hospitals, clinics and other health care facilities can boost frontline staffs during the pandemic.
In light of the toll the COVID-19 pandemic is taking on the well-being of clinicians, the Action Collaborative on Clinician Well-Being compiled a list of strategies and resources to support those on the front lines.
The latest Centers for Disease Control and Prevention (CDC) infection control guidance focuses on limiting the ways germs can enter a facility, quickly isolating symptomatic patients and protecting health care personnel.
To provide decision makers with a snapshot of hospitals' challenges and needs during the COVID-19 pandemic, the office of the inspector general at the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) conducted a national survey between March 23 and March 27.
To help prevent the spread in health care facilities of the virus causing COVID-19, the Centers for Disease Control and Prevention (CDC) released updated guidance this week on discharging hospitalized patients with COVID-19.